Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
MIXED(1)
2 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01676753Phase 1Completed
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer
Advanced or Metastatic Breast CancerTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2016-12-28
NCT01384526Completed
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Breast CancerFertility
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01676753Phase 1PrincipalInvestigator

Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer

Advanced or Metastatic Breast CancerTriple Negative Breast Cancer
Completed
NCT01384526PrincipalInvestigator

Investigating the Impact of Tamoxifen Therapy on Ovarian Aging

Breast CancerFertility
Completed

All 2 trials loaded